These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 16383333)

  • 1. Simultaneous determination of pKa and lipophilicity by gradient RP HPLC.
    Wiczling P; Kawczak P; Nasal A; Kaliszan R
    Anal Chem; 2006 Jan; 78(1):239-49. PubMed ID: 16383333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new pH/organic modifier gradient RP HPLC method for convenient determination of lipophilicity and acidity of drugs as applied to established imidazoline agents.
    Wiczling P; Nasal A; Kubik Ł; Kaliszan R
    Eur J Pharm Sci; 2012 Aug; 47(1):1-5. PubMed ID: 22565065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-throughput evaluation of lipophilicity and acidity by new gradient HPLC methods.
    Markuszewski MJ; Wiczling P; Kaliszan R
    Comb Chem High Throughput Screen; 2004 Jun; 7(4):281-9. PubMed ID: 15200377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The simultaneous determination of hydrophobicity and dissociation constant by liquid chromatography-mass spectrometry.
    Wiczling P; Struck-Lewicka W; Kubik L; Siluk D; Markuszewski MJ; Kaliszan R
    J Pharm Biomed Anal; 2014 Jun; 94():180-7. PubMed ID: 24598171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. pH gradient high-performance liquid chromatography: theory and applications.
    Kaliszan R; Wiczling P; Markuszewski MJ
    J Chromatogr A; 2004 Dec; 1060(1-2):165-75. PubMed ID: 15628159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simultaneous determination of hydrophobicity and dissociation constant for a large set of compounds by gradient reverse phase high performance liquid chromatography-mass spectrometry technique.
    Kubik Ł; Struck-Lewicka W; Kaliszan R; Wiczling P
    J Chromatogr A; 2015 Oct; 1416():31-7. PubMed ID: 26365909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. pH/organic solvent double-gradient reversed-phase HPLC.
    Wiczling P; Markuszewski MJ; Kaliszan M; Kaliszan R
    Anal Chem; 2005 Jan; 77(2):449-58. PubMed ID: 15649040
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipophilicity and pKa estimates from gradient high-performance liquid chromatography.
    Kaliszan R; Haber P; Baczek T; Siluk D; Valko K
    J Chromatogr A; 2002 Aug; 965(1-2):117-27. PubMed ID: 12236521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipophilicity measurement of drugs by reversed phase HPLC over Wide pH range using an alkaline-resistant silica-based stationary phase, XBridge Shield RP(18).
    Liu X; Hefesha H; Tanaka H; Scriba G; Fahr A
    Chem Pharm Bull (Tokyo); 2008 Oct; 56(10):1417-22. PubMed ID: 18827381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determination of pKa by pH gradient reversed-phase HPLC.
    Wiczling P; Markuszewski MJ; Kaliszan R
    Anal Chem; 2004 Jun; 76(11):3069-77. PubMed ID: 15167784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipophilicity determination of highly lipophilic compounds by liquid chromatography.
    Guillot A; Henchoz Y; Moccand C; Guillarme D; Veuthey JL; Carrupt PA; Martel S
    Chem Biodivers; 2009 Nov; 6(11):1828-36. PubMed ID: 19937824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Theoretical opportunities and actual limitations of pH gradient HPLC.
    Kaliszan R; Wiczling P
    Anal Bioanal Chem; 2005 Jun; 382(3):718-27. PubMed ID: 15719233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The application of gradient reversed-phase high-performance liquid chromatography to the pK(a) and log k(w) determination of polyprotic analytes.
    Wiczling P; Waszczuk-Jankowska M; Markuszewski MJ; Kaliszan R
    J Chromatogr A; 2008 Dec; 1214(1-2):109-14. PubMed ID: 18992894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of pH on retention in linear organic modifier gradient RP HPLC.
    Wiczling P; Kaliszan R
    Anal Chem; 2008 Oct; 80(20):7855-61. PubMed ID: 18781775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Capillary electrochromatography as a new tool to assess drug affinity for membrane phospholipids.
    Barbato F; Grumetto L; Carpentiero C; Rocco A; Fanali S
    J Pharm Biomed Anal; 2011 Apr; 54(5):893-9. PubMed ID: 21168987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Physicochemical characterization of ricobendazole: I. Solubility, lipophilicity, and ionization characteristics.
    Wu Z; Razzak M; Tucker IG; Medlicott NJ
    J Pharm Sci; 2005 May; 94(5):983-93. PubMed ID: 15793800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isocratic RP-HPLC method for rutin determination in solid oral dosage forms.
    Kuntić V; Pejić N; Ivković B; Vujić Z; Ilić K; Mićić S; Vukojević V
    J Pharm Biomed Anal; 2007 Jan; 43(2):718-21. PubMed ID: 16920326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An increased throughput method for the determination of partition coefficients.
    Hitzel L; Watt AP; Locker KL
    Pharm Res; 2000 Nov; 17(11):1389-95. PubMed ID: 11205732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Physicochemical profile of nimesulide. Exploring the interplay of lipophilicity, solubility and ionization.
    Dellis D; Giaginis C; Tsantili-Kakoulidou A
    J Pharm Biomed Anal; 2007 May; 44(1):57-62. PubMed ID: 17336024
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of variation in mobile phase pH and solute pK(a) with the change of organic modifier fraction on QSRRs of hydrophobicity and RP-HPLC retention of weakly acidic compounds.
    Han SY; Liang C; Zou K; Qiao JQ; Lian HZ; Ge X
    Talanta; 2012 Nov; 101():64-70. PubMed ID: 23158292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.